NasdaqGS:PODDMedical Equipment
Is Class Action Scrutiny Of Omnipod Controls Altering The Investment Case For Insulet (PODD)?
In the past week, law firms Robbins Geller Rudman & Dowd LLP and Rosen Law Firm announced securities class action lawsuits against Insulet, alleging false or misleading statements about manufacturing controls and safety risks in its insulin delivery products for investors who bought shares between February 21, 2025 and May 26, 2026.
A key implication is that questions around product quality oversight and corporate disclosure practices now sit alongside Insulet’s growth story in diabetes...